These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1387838)

  • 1. Atrial and brain natriuretic peptides: secretion during exercise in patients with essential hypertension and modulation by acute angiotensin-converting enzyme inhibition.
    Kohno M; Horio T; Yokokawa K; Murakawa K; Yasunari K; Kurihara N; Takeda T
    Clin Exp Pharmacol Physiol; 1992 Mar; 19(3):193-200. PubMed ID: 1387838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic effect of beta-adrenoceptor blockade on plasma levels of brain natriuretic peptide during exercise in essential hypertension.
    Tanaka M; Ishizaka Y; Ishiyama Y; Kato J; Kida O; Kitamura K; Kangawa K; Eto T
    Hypertens Res; 1996 Dec; 19(4):239-45. PubMed ID: 8986454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
    J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension.
    Pidgeon GB; Richards AM; Nicholls MG; Espiner EA; Yandle TG; Frampton C
    Hypertension; 1996 Apr; 27(4):906-13. PubMed ID: 8613267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction.
    Marumoto K; Hamada M; Aburaya M; Hiwada K
    Jpn Circ J; 1995 Nov; 59(11):715-24. PubMed ID: 8747761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects.
    Nishikimi T; Morimoto A; Ishikawa K; Saito Y; Kangawa K; Matsuo H; Kitamura K; Takishita S; Matsuoka H
    Clin Exp Hypertens; 1997 May; 19(4):503-18. PubMed ID: 9140711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial brain natriuretic peptide concentration and cardiopulmonary hemodynamics during exercise in patients with essential hypertension.
    Kohno M; Horio T; Yokokawa K; Akioka K; Ikeda M; Takeda T
    Metabolism; 1992 Dec; 41(12):1273-5. PubMed ID: 1461132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
    Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced secretion of brain natriuretic peptide in essential hypertension and normal subjects.
    Tanaka M; Ishizaka Y; Ishiyama Y; Kato J; Kida O; Kitamura K; Kangawa K; Matsuo H; Eto T
    Hypertens Res; 1995 Jun; 18(2):159-66. PubMed ID: 7584923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
    Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopeptidase inhibition: a new concept in blood pressure management.
    Burnett JC
    J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acute ACE inhibition on atrial natriuretic peptide.
    Doorenbos CJ; van Brummelen P
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):243S-247S. PubMed ID: 2527537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
    Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
    Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.